User Fee Reauthorization Needed By August To Avoid Staff Layoffs
Executive Summary
FDA will initiate staff layoffs if Congress does not reauthorize prescription drug user fees by August, HHS Deputy Assistant Secretary for Budget and Health Science Legislation Craig Burton warned May 17
You may also be interested in...
FDA Receives Assurances That PDUFA Remains Priority on Capitol Hill
As Congress prepared to adjourn for summer recess without reauthorizing the Prescription Drug User Fee Act, FDA Commissioner Andrew von Eschenbach sent an e-mail to agency employees Aug. 3 designed to lessen worries about job security
FDA Receives Assurances That PDUFA Remains Priority on Capitol Hill
As Congress prepared to adjourn for summer recess without reauthorizing the Prescription Drug User Fee Act, FDA Commissioner Andrew von Eschenbach sent an e-mail to agency employees Aug. 3 designed to lessen worries about job security
FDA Reform Bills Grow Similar As House/Senate Conference Committee Nears
The recently passed House FDA reform bill (H.R. 2900) includes several last-minute changes that bring it closer to the Senate version (S. 1082), suggesting Congressional efforts to ease the prospective merge of the bills in the upcoming Conference Committee